Corrigendum to “Full-Endoscopic versus Minimally Invasive Lumbar Interbody Fusion for Lumbar Degenerative Diseases : A Systematic Review and Meta-Analysis” by Son et al. (J Korean Neurosurg Soc 65 : 539-548, 2022)

Article information

J Korean Neurosurg Soc. 2022;65(6):875-875

Publication date (electronic) : 2022 October 19

doi : https://doi.org/10.3340/jkns.2021.0168.e1

This corrects the article "Full-Endoscopic versus Minimally Invasive Lumbar Interbody Fusion for Lumbar Degenerative Diseases : A Systematic Review and Meta-Analysis" on page 539.

https://doi.org/10.3340/jkns.2021.0168

This correction is being published to correct the use of the term “Endo-LIF” as an abbreviation for full-endoscopic lumbar interbody fusion due to its similarity to a trademarked term “EndoLIF®” registered by Joimax®.

Before correction

“Endo-LIF” as an abbreviation for endoscopic lumbar interbody fusion

After correction

“ELIF” as an abbreviation for endoscopic lumbar interbody fusion

The authors were unaware that the terminology was trademarked and had no intentions of using the trademarked term as our own. We would like to apologize for any inconvenience caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.